Shares in French biotech Abivax tumbled more than 30% today, after it announced phase 3 data with ulcerative colitis (UC) candidate obefazimod that showed strong efficacy, but also cases of cancer ...

The FDA issued approvals for Pfizer and Moderna's 2026 COVID-19 vaccines on Thursday, but is recommending them for the same ...

Developing new drugs and therapies is a contact sport for research sites. Investigators are on the frontlines, meeting and ...

Sword Health, a digital therapeutics company that started in the physical therapy space, has acquired digital mental health ...

The US FDA has green lit ViiV Healthcare’s Tivicay PD (dolutegravir) for the treatment of HIV-1 in children weighing at least ...

Pharmaceutical portfolio decision-making is facing structural pressure. Patent expirations, rising development costs, ...

Medical technology company Boston Scientific became the target of a cyberattack this week, which disrupted some of its IT ...

The ambition to build a Phase I oncology clinical development centre can be deceptively simple. The temptation is to ...

US President Donald Trump has nominated White House health policy aide Heidi Overton to take up the mantle of commissioner ...

Cambridge, UK-based Neurocrine Biosciences - partnered with Japan’s Nxera Pharma - has announced it has received IND ...

Roche’s Genentech has agreed a deal worth up to $2.3 billion to develop and sell Hanmi Pharmaceutical’s experimental obesity ...

The Marcus Evans AI, Forecasting, Insights and Analytics for Smarter Decisions in Pharma conference will explore how pharma ...